AZRX - AzurRx BioPharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development4,985.5532,395.4782,496.1051,398.056
Selling General and Administrative8,236.2187,685.7064,129.0533,330.752
Non Recurring----
Others----
Total Operating Expenses13,221.77110,081.1846,625.1584,728.808
Operating Income or Loss-13,221.771-10,081.184-6,625.158-4,728.808
Income from Continuing Operations
Total Other Income/Expenses Net-311.846-1,015.199-7,966.504-1,201.428
Earnings Before Interest and Taxes-13,221.771-10,081.184-6,625.158-4,728.808
Interest Expense-101.846-875.199-5,937.486-1,587.533
Income Before Tax-13,533.617-11,096.383-14,591.662-5,930.236
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-13,533.617-11,096.383-14,591.662-5,930.236
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,533.617-11,096.383-14,591.662-5,930.236
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-13,533.617-11,096.383-14,591.662-5,930.236